Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)

NCT02615145 · clinicaltrials.gov ↗
COMPLETED
Status
472
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie